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Abstract 
Activation of 5-HT6 receptors stimulates attentional switching and 5-HT6 receptor antagonists 
are putative drugs for psychosis. Latent inhibition (LI) provides a pre-clinical model of 
attentional switching and ‘antipsychotic-like’ action and is known to be modulated by 5-HT. 
In the present study, LI was shown in a fear conditioning procedure which measured 
suppression of drinking after conditioning with footshock. In two experiments (each N=48) it 
was shown that pre-exposure to both light and noise conditioned stimuli reduced conditioned 
suppression relative to the corresponding non-pre-exposed control. However, counter to 
prediction, LI was intact after treatment with the 5-HT6 agonist EMD386088 (5mg/kg).  
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Introduction 
Amongst the multiplicity of 5-HT receptor sub-types, the 5-HT6 receptor in particular is located 
in brain regions involved in learning and memory (Fone, 2008; Ivachtchenko et al, 2016). 
Consistent with this receptor distribution, 5-HT6 receptor antagonists can improve learning and 
memory in a variety of procedures (Fone, 2008; Ivachtchenko et al, 2016). However, the 
evidence for their efficacy in animal models for schizophrenia is limited (Gravius et al., 2001). 
Latent inhibition (LI) provides a pre-clinical model of attentional switching to test drugs for 
psychosis (Weiner, 1990; Nelson et al., 2011). Specifically LI refers to the reduction in 
associative learning produced by pre-exposure to the intended conditioned stimulus (CS), 
relative to a non-pre-exposed group for which the CS is novel. With experimental parameters 
set to produce weak LI in controls, there was no evidence for enhancement of LI following 
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treatment with 5-HT6 antagonists (Leng et al., 2003). However, a variety of serotonergic 
manipulations have well-documented effects on LI (Weiner, 1990) and the effects of 5-HT6 
agonists have not been reported. 
In the present study, a similar fear conditioning procedure (suppression of drinking after 
conditioning with footshock) was used to test the prediction that treatment with the 5-HT6 
agonist EMD386088 should reduce LI, by restoring conditioning to the pre-exposed stimuli. 
EMD386088 was administered at 5mg/kg, the dose previously identified to attenuate prior 
learning in a similar fear conditioning procedure (Supplementary Material). This dose also 
restored fear conditioning which was attenuated because of cholinergic hypoactivity 
(Woods et al., 2012).  
 
Methods  
For each experiment, 48 experimentally naïve adult male Wistar rats (Charles River, UK; 
average start weight 220g) were caged in pairs on a 12:12h light/dark cycle with ad libitum 
food. All procedures were carried out in accordance with the United Kingdom (UK) Animals 
Scientific Procedures Act 1986, Project Licence number: PPL40/3163 and following an 
established LI procedure (Nelson et al., 2011). 
Water deprivation was used to motivate licking in a conditioned suppression of drinking 
procedure, conducted within six automated conditioning boxes (Cambridge Cognition, 
Cambridge, UK). In Experiment 1, a flashing light of overall 5s duration served as the CS for 
the control group of rats and was first presented without consequence (x30) in the pre-exposed 
(PE) groups. In Experiment 2, a 5s mixed frequency noise set at 85dB served as the CS for 
control group and was first presented without consequence (x30) in the PE groups. In both 
experiments, scrambled footshock of 1s duration and 1mA intensity provided the 
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unconditioned stimulus (Nelson et al., 2011). Both experiments used a 4-day procedure for 
pre-exposure, conditioning, reshaping and test (Nelson et al., 2011). 
EMD386088 HCl (Tocris, UK) was dissolved in saline at 5mg/ml for injection (i.p.) at 1ml/kg 
to administer a dose of 5mg/kg. Drug or saline (1ml/kg) control injections were administered 
30 min prior to the pre-exposure and conditioning stages of the LI procedure. 
Associative learning and LI thereof was measured as suppression ratios.  
 
Results 
 
 
In both experiments, the baseline licking scores seen pre-conditioning confirmed that the rats 
were well-matched across their experimental allocations (Table 1). As might be expected, after 
conditioning the latencies to drink in the boxes were longer and the rats drank less, reflecting 
fear conditioning to context measured on the reshaping day. However, there was no effect of 
EMD386088 on fear conditioning to context in either experiment. 
----- Table 1 about here ----- 
Effects of EMD386088 on latent inhibition with a light CS  
 
In the key conditioned suppression tests (Figure 1A) data from one rat was lost due to 
equipment failure. There was a main effect of conditioning group [F(1,43)=18.41, p<0.001]. 
Thus LI was demonstrated with the light CS.  However, there was no effect of drug, either 
overall or in interaction with pre-exposure [maximum F(1,43)=0.352].  
----- Figure 1 about here ----- 
Effects of EMD386088 on latent inhibition with a noise CS  
ANOVA showed a main effect of conditioning group [F(1,44)=12.46, p=0.001]. Thus LI was 
also demonstrated with the noise CS (Figure 1B). However, there was no effect of drug, either 
overall or in interaction with pre-exposure [maximum F(1,44)=0.21].  
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Conclusions  
Contrary to prediction, there was no indication of any effect of 5mg/kg EMD386088 on LI. It 
is a limitation of the present study that further doses were not examined. However, the dose 
selected for use has previously been reported effective (Woods et al., 2012). The present study 
used 30 pre-exposures to the subsequent CS, resulting in robust LI irrespective of whether this 
stimulus was light (Experiment 1) or noise (Experiment 2). Since in common with 5-HT6 
antagonists, 5-HT6 agonists can show paradoxical pro-cognitive effects (Fone 2008) and 
EMD386088 is a partial agonist with an irregular dose-response (Jastrzębska-Więsek et al., 
2013), it remains possible that LI enhancement under EMD386088 could be revealed under 
conditions of fewer pre-exposures, drug-induced impairment, or at a different dose.  
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Measure 
Saline 
(N=24 x2) 
EMD386088 
5mg/kg 
(N=24 x2) 
Statistics for 
main effect 
of drug (p) 
Statistics for 
drug x pre-
exposure 
interaction (p) 
Experiment 1      
Pre-
conditioning  
latency 5.21  
(1.29) 
6.25  
(1.47) 
0.60 0.95 
 min 1 licks 280.92 
(8.28) 
276.50 
(10.99) 
0.75 0.25 
 total licks 1860.38 
(101.06) 
1906.46 
(98.11) 
0.75 0.98 
Reshaping  latency 162.79 
(49.92) 
108.71 
(27.94) 
0.36 0.92 
 min 1 licks 227.17 
(17.21) 
200.58 
(21.14) 
0.35 0.89 
 total licks 1676.75 
(119.95) 
1627.21 
(126.72) 
0.78 0.99 
Experiment 2      
Pre-
conditioning  
latency 7.38  
(1.85) 
6.92  
(2.42) 
0.88 0.61 
 min 1 licks 284.42 
(14.09) 
281.79 
(13.56) 
0.89 0.36 
 total licks 1931.58  
(114.76) 
1862.75 
(96.36) 
0.65 0.34 
Reshaping  latency 23.13  
(4.41) 
66.83 
(22.94) 
0.07 0.57 
 min 1 licks 236.46 
(18.80) 
197.92 
(22.12) 
0.19 0.98 
 total licks 1819.08 
(118.80) 
1712.25 
(73.91) 
0.45 0.54 
 
Table 1. Mean lick latencies and numbers of licks (±S.E.M.) in Experiments 1 and 2 
(N=24/drug group/experiment). Data were analysed with between subjects factors of drug 
(saline, EMD386088) and the allocated behavioural condition (pre-exposed, non-pre-
exposed). The p values shown are for the main effect of drug and for the interaction term. 
There were 5 days of pre-conditioning during which rats became accustomed to drinking in 
the boxes. The data from the 5th day are shown for direct comparison with the reshaping day 
which followed pre-exposure and conditioning under drug. 
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Figure 1: (A) Mean suppression ratio (±S.E.M.) to the light for control (light blue) and 
preexposed (PE; dark orange) groups following treatment with saline or 5mg/kg EMD386088 
in Experiment 1 (N=47). (B) Mean suppression ratio (±S.E.M.) to the noise for control (light 
blue) and preexposed (PE; dark orange) groups following treatment with saline or 5mg/kg 
EMD386088 in Experiment 2 (N=48).  
 
 
